Liquidia Settles Patent Dispute With United Therapeutics for $380.7M
Liquidia Corporation announced a global settlement with United Therapeutics on Monday that ends years of litigation and secures continued sales of its YUTREPIA inhalation powder for pulmonary arterial hypertension. LQDA shares rose approximately 51% in after-hours trading following the
GateMacroTradfiHub·10-14 02:13
